Nanocarrier-Based Targeted Therapies for Myocardial Infarction

Myocardial infarction is a major cause of morbidity and mortality worldwide. Due to poor inherent regeneration of the adult mammalian myocardium and challenges with effective drug delivery, there has been little progress in regenerative therapies. Nanocarriers, including liposomes, nanoparticles, an...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Thomashire A., Hsu, Chuan-Chih, Meeson, Annette, Lundy, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143269/
https://www.ncbi.nlm.nih.gov/pubmed/35631516
http://dx.doi.org/10.3390/pharmaceutics14050930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143269/
https://www.ncbi.nlm.nih.gov/pubmed/35631516
http://dx.doi.org/10.3390/pharmaceutics14050930

Ejemplares similares